Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Jan M. Leerink"'
Autor:
Jan M. Leerink, Elizabeth A. M. Feijen, Perry D. Moerland, Esmee C. de Baat, Remy Merkx, Helena J. H. van der Pal, Wim J. E. Tissing, Marloes Louwerens, Marry M. van den Heuvel‐Eibrink, A. Birgitta Versluys, Folkert W. Asselbergs, Arjan Sammani, Arco J. Teske, Elvira C. van Dalen, Margriet van der Heiden‐van der Loo, Eline van Dulmen‐den Broeder, Andrica C. H. de Vries, Livia Kapusta, Jacqueline Loonen, Yigal M. Pinto, Leontien C. M. Kremer, Annelies M. C. Mavinkurve‐Groothuis, Wouter E. M. Kok
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 11, Iss 14 (2022)
Background Plasma biomarkers may aid in the detection of anthracycline‐related cardiomyopathy (ACMP). However, the currently available biomarkers have limited diagnostic value in long‐term childhood cancer survivors. This study sought to identify
Externí odkaz:
https://doaj.org/article/82e6291c6713455590d77cad399df447
Autor:
Jan M. Leerink, MD, Esmée C. de Baat, MD, Elizabeth A.M. Feijen, PhD, Louise Bellersen, MD, Elvira C. van Dalen, MD, PhD, Heynric B. Grotenhuis, MD, PhD, Livia Kapusta, MD, PhD, Wouter E.M. Kok, MD, PhD, Jacqueline Loonen, MD, PhD, Heleen J.H. van der Pal, MD, PhD, Saskia M.F. Pluijm, PhD, Arco J. Teske, MD, PhD, Annelies M.C. Mavinkurve-Groothuis, MD, PhD, Remy Merkx, MD, Leontien C.M. Kremer, MD, PhD
Publikováno v:
JACC. CardioOncology, Vol 2, Iss 3, Pp 363-378 (2020)
Cardiac diseases in the growing population of childhood cancer survivors are of major concern. Cardiotoxicity as a consequence of anthracyclines and chest radiotherapy continues to be relevant in the modern treatment era. Mitoxantrone has emerged as
Externí odkaz:
https://doaj.org/article/5ac9d07f182b4f83856099d92bde6a1c
Autor:
Matthew J Ehrhardt, Jan M Leerink, Renée L Mulder, Annelies Mavinkurve-Groothuis, Wouter Kok, Anju Nohria, Paul C Nathan, Remy Merkx, Esmée de Baat, Ogechukwu A Asogwa, Roderick Skinner, Hamish Wallace, E A M Lieke Feijen, Maëlle de Ville de Goyet, Maya Prasad, Edit Bárdi, Vesna Pavasovic, Helena van der Pal, Brice Fresneau, Charlotte Demoor-Goldschmidt, Ulrike Hennewig, Julia Steinberger, Chris Plummer, Ming Hui Chen, Arco J Teske, Nadia Haddy, Elvira C van Dalen, Louis S Constine, Eric J Chow, Gill Levitt, Melissa M Hudson, Leontien C M Kremer, Saro H Armenian
Publikováno v:
Lancet Oncology, 24, E108-E120
Lancet Oncology, 24, 3, pp. E108-E120
Lancet Oncology, 24, 3, pp. E108-E120
Item does not contain fulltext
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9b8979d43c378548a04b356baf35a402
http://hdl.handle.net/2066/291613
http://hdl.handle.net/2066/291613
Autor:
Leontien C. M. Kremer, Wouter E.M. Kok, Mabel van de Ruit, Elizabeth A M Feijen, Esther E. Creemers, Annelies M. C. Mavinkurve-Groothuis, Yigal M. Pinto, Jan M. Leerink
Publikováno v:
Journal of Molecular Medicine (Berlin, Germany)
As in other cardiomyopathies, extracellular matrix (ECM) remodeling plays an important role in anthracycline-induced cardiomyopathy. To understand the pattern and timing of ECM remodeling pathways, we conducted a systematic review in which we describ
Autor:
Chris L. de Korte, Esmée C de Baat, Marloes Louwerens, Elisabeth Lieke A M Feijen, Elvira C. van Dalen, Wim J. E. Tissing, Helena J H van der Pal, Margriet van der Heiden-van der Loo, Wouter E.M. Kok, Leontien C. M. Kremer, Gert Weijers, Arco J. Teske, Livia Kapusta, Angela H.E.M. Maas, Marry M. van den Heuvel-Eibrink, Eline van Dulmen-den Broeder, Cécile M. Ronckers, Remy Merkx, Jacqueline J. Loonen, Annelies M. C. Mavinkurve-Groothuis, Louise Bellersen, Andrica C H de Vries, Yigal M. Pinto, Jan M. Leerink
Publikováno v:
Echocardiography
Echocardiography, 38(6), 951-963. WILEY
Echocardiography : a Journal of Cardiovascular Ultrasound and Allied Techniques, 38, 951-963
Echocardiography (Mount Kisco, N.Y.), 38(6), 951-963. Wiley-Blackwell
Echocardiography : a Journal of Cardiovascular Ultrasound and Allied Techniques, 38, 6, pp. 951-963
Echocardiography (Mount Kisco, N.y.)
Echocardiography-A journal of cardiovascular ultrasound and allied techniques, 38(6), 951-963. Wiley-Blackwell
Echocardiography, 38(6), 951-963. WILEY
Echocardiography : a Journal of Cardiovascular Ultrasound and Allied Techniques, 38, 951-963
Echocardiography (Mount Kisco, N.Y.), 38(6), 951-963. Wiley-Blackwell
Echocardiography : a Journal of Cardiovascular Ultrasound and Allied Techniques, 38, 6, pp. 951-963
Echocardiography (Mount Kisco, N.y.)
Echocardiography-A journal of cardiovascular ultrasound and allied techniques, 38(6), 951-963. Wiley-Blackwell
Contains fulltext : 235000.pdf (Publisher’s version ) (Open Access) BACKGROUND: Cardiotoxicity is a well-known side effect after anthracyclines and chest radiotherapy in childhood cancer survivors (CCS). The DCCSS LATER 2 CARD (cardiology) study in
Autor:
Joris R. de Groot, Louise Harris, Isabelle C. Van Gelder, Maarten Groenink, Werner Budts, Barbara J.M. Mulder, Aeilko H. Zwinderman, Jan M. Leerink, Zeliha Koyak, José M. Oliver, Rafael Peinado Peinado, Daniëlle Robbers-Visser, Jim T. Vehmeijer, Robbert J. de Winter, Berto J. Bouma, Erwin Oechslin, S. Matthijs Boekholdt
Publikováno v:
Heart rhythm, 18(5), 785-792. Elsevier
Heart Rhythm, 18(5), 785-792. ELSEVIER SCIENCE INC
Heart Rhythm, 18(5), 785-792. ELSEVIER SCIENCE INC
BACKGROUND: Sudden cardiac death (SCD) is the main preventable cause of death in patients with adult congenital heart disease (ACHD). Since robust risk stratification methods are lacking, we developed a risk score model to predict SCD in patients wit
Autor:
Elvira C. van Dalen, Chris L. de Korte, Wouter E.M. Kok, Leontien C. M. Kremer, Helena J H van der Pal, Jan M. Leerink, Louise Bellersen, Annelies M. C. Mavinkurve-Groothuis, Elizabeth A M Feijen, Esmée C de Baat, Jacqueline J. Loonen, Livia Kapusta, Remy Merkx
Publikováno v:
Journal of Cancer Survivorship, 16, 338-352
Journal of Cancer Survivorship, 16, 2, pp. 338-352
Journal of Cancer Survivorship, 16, 2, pp. 338-352
Purpose Echocardiographic surveillance for asymptomatic left ventricular systolic dysfunction (ALVSD) is advised in childhood cancer survivors (CCS), because of their risk of heart failure after anthracycline treatment. ALVSD can be assessed with dif
Autor:
Esmée C de Baat, Elvira C van Dalen, Renée L Mulder, Melissa M Hudson, Matthew J Ehrhardt, Frederike K Engels, Elizabeth A M Feijen, Heynric B Grotenhuis, Jan M Leerink, Livia Kapusta, Gertjan J L Kaspers, Remy Merkx, Luc Mertens, Roderick Skinner, Wim J E Tissing, Florent de Vathaire, Paul C Nathan, Leontien C M Kremer, Annelies M C Mavinkurve-Groothuis, Saro Armenian
Publikováno v:
de Baat, E C, van Dalen, E C, Mulder, R L, Hudson, M M, Ehrhardt, M J, Engels, F K, Feijen, E A M, Grotenhuis, H B, Leerink, J M, Kapusta, L, Kaspers, G J L, Merkx, R, Mertens, L, Skinner, R, Tissing, W J E, de Vathaire, F, Nathan, P C, Kremer, L C M, Mavinkurve-Groothuis, A M C & Armenian, S 2022, ' Primary cardioprotection with dexrazoxane in patients with childhood cancer who are expected to receive anthracyclines : recommendations from the International Late Effects of Childhood Cancer Guideline Harmonization Group ', The Lancet Child and Adolescent Health, vol. 6, no. 12, pp. 885-894 . https://doi.org/10.1016/S2352-4642(22)00239-5
The Lancet Child & Adolescent Health, 6, 885-894
The Lancet Child & Adolescent Health, 6, 12, pp. 885-894
The Lancet Child & Adolescent Health, 6, 885-894
The Lancet Child & Adolescent Health, 6, 12, pp. 885-894
Item does not contain fulltext Survivors of childhood cancer are at risk of anthracycline-induced cardiotoxicity, which might be prevented by dexrazoxane. However, concerns exist about the safety of dexrazoxane, and little guidance is available on it
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e933dd197d23cbe7070b694086dff1e7
https://doi.org/10.1016/S2352-4642(22)00239-5
https://doi.org/10.1016/S2352-4642(22)00239-5
Autor:
Elizabeth A M Feijen, Elvira C. van Dalen, Heleen J H van der Pal, Livia Kapusta, Wouter E.M. Kok, Arco J. Teske, Jacqueline J. Loonen, Saskia M F Pluijm, Louise Bellersen, Leontien C. M. Kremer, Esmée C de Baat, Annelies M. C. Mavinkurve-Groothuis, Heynric B. Grotenhuis, Jan M. Leerink, Remy Merkx
Publikováno v:
JACC. CardioOncology, Vol 2, Iss 3, Pp 363-378 (2020)
Cardiac diseases in the growing population of childhood cancer survivors are of major concern. Cardiotoxicity as a consequence of anthracyclines and chest radiotherapy continues to be relevant in the modern treatment era. Mitoxantrone has emerged as
Autor:
Jacqueline J. Loonen, Wouter E.M. Kok, Milanthy S. Pourier, Paola G. Meregalli, Elizabeth A.M. Feijen, Helena J.H. van der Pal, Livia Kapusta, Leontien C. M. Kremer, Yigal M. Pinto, Remy Merkx, Jan M. Leerink, Annelies M. C. Mavinkurve-Groothuis, Elvira C. van Dalen, Louise Bellersen
Publikováno v:
JACC. CardioOncology, 3, 1, pp. 62-72
JACC. CardioOncology, 3, 62-72
JACC: CardioOncology
JACC: CardioOncology, 3(1), 62-72. Elsevier Inc.
JACC. CardioOncology, 3, 62-72
JACC: CardioOncology
JACC: CardioOncology, 3(1), 62-72. Elsevier Inc.
Background In childhood cancer survivors (CCS) at risk for heart failure, echocardiographic surveillance recommendations are currently based on anthracyclines and chest-directed radiotherapy dose. Whether the ejection fraction (EF) measured at an ini
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::60702291d947d4b5229b9abfc5d7abcb
https://doi.org/10.1016/j.jaccao.2020.11.013
https://doi.org/10.1016/j.jaccao.2020.11.013